Having explored the mechanisms behind the ability of clinical HP-13C-MRI to detect PCa by distinguishing it from the healthy tissue, we then assessed the differential [1-13C]lactate labelling between tumours harbouring cribriform and non-cribriform GP4 disease. This evidence concerns the gene CD36 and posterior cortical atrophy.